1 Min Read
Feb 10 (Reuters) - Celgene Switzerland LLC:
* Celgene Switzerland LLC reports passive stake of 10.8 percent in Jounce Therapeutics Inc as on February 1, 2017 - SEC filing Source text: (bit.ly/2kR99eh) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.